Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Aspects influencing genotyping method selection.

Peter Imle1

  • 1Hartwell Center for Bioinformatics and Biotechnology, St. Jude Children's Research Hospital, Memphis, TN, USA.

Methods in Molecular Biology (Clifton, N.J.)
|August 16, 2005
PubMed
Summary

Advancements in genotyping methods are expanding pharmacogenomics. Understanding the limitations of genotyping techniques and polymorphisms is crucial for successful pharmacogenomic study integration.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fluorescence-based fragment size analysis.

Methods in molecular biology (Clifton, N.J.)ยท2005
See all related articles

Area of Science:

  • Pharmacogenomics
  • Genetics
  • Biotechnology

Background:

  • Pharmacogenomics has expanded due to advancements in genotyping technologies.
  • Historically, limited genotyping capabilities hindered the use of pharmacogenomic data.
  • Current high-throughput genotyping offers flexibility but requires careful consideration of limitations.

Purpose of the Study:

  • To provide an overview of the constraints associated with various genotyping methods in pharmacogenomics.
  • To discuss factors influencing the choice of genotyping methods based on polymorphisms and study type.
  • To highlight key aspects for integrating genotyping data into pharmacogenomic studies.

Main Methods:

  • Review of current genotyping platforms and chemistries.
  • Analysis of limitations imposed by specific polymorphisms.
  • Evaluation of study design considerations for pharmacogenomic data generation.

Main Results:

  • Genotyping method capabilities have evolved, enabling wider pharmacogenomic research.
  • Limitations exist based on the polymorphisms being studied and the specific pharmacogenomic application.
  • Careful selection of genotyping methods is essential for reliable pharmacogenomic data.

Conclusions:

  • The choice of genotyping method must align with the specific genetic variations and research goals in pharmacogenomics.
  • Understanding method limitations is key to maximizing the utility of genotyping data in pharmacogenomics.
  • Successful integration of genotyping into pharmacogenomic studies requires a strategic approach to method selection and data interpretation.

Related Experiment Videos